FORTIS.NS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 17:59):

Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India, the United Arab Emirates, Sri Lanka, and internationally...

Stats
今日成交量	1.93M
平均成交量	1.34M
市值	348.34B
EPS	INR0 ( 2024-02-06 )
下一个收益日期	( INR1.940 ) 2024-05-21
Last Dividend	INR1.000 ( 2023-07-20 )
Next Dividend	INR0 ( N/A )
P/E	63.03
ATR14	INR0.614 (0.13%)

音量相关性

長: -0.16 (neutral)

短: 0.91 (very strong)

Signal:(71.536) Expect same movement, but be aware

Fortis Healthcare Limited 相关性

10 最正相关
NOVARTIND.NS	0.907
BAYERCROP.NS	0.901
PIONEEREMB.NS	0.901
BIOFILCHEM.NS	0.9
TNPETRO.NS	0.896
AJRINFRA.NS	0.896
FSC.NS	0.895
GANGAFORGE.NS	0.895
DIAMONDYD.NS	0.894
SUULD.NS	0.891

10 最负相关
TARMAT.NS	-0.888
HARIOMPIPE.NS	-0.864
CIGNITITEC.NS	-0.862
SOMATEX.NS	-0.861
KIRLFER.NS	-0.861
KAYNES.NS	-0.861
SIEMENS.NS	-0.858
ISMTLTD.NS	-0.856
SONATSOFTW.NS	-0.855
BSELINFRA.NS	-0.853

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Fortis Healthcare Limited 相关性 - 货币/商品

0.68
( moderate )

0.74
( moderate )

0.71
( moderate )

0.51
( weak )

0.35
( neutral )

0.16
( neutral )

Fortis Healthcare Limited 财务报表

Annual	2022
营收:	INR62.98B
毛利润:	INR35.31B (56.08 %)
EPS:	INR7.80

FY	2022
营收:	INR62.98B
毛利润:	INR35.31B (56.08 %)
EPS:	INR7.80

FY	2022
营收:	INR56.39B
毛利润:	INR42.21B (74.85 %)
EPS:	INR10.46

FY	2021
营收:	INR40.09B
毛利润:	INR21.65B (54.00 %)
EPS:	INR-1.450

Financial Reports:

No articles found.

Fortis Healthcare Limited Dividends

(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR1.000 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Fortis Healthcare Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.45 - low (14.69%) | Divividend Growth Potential Score: 4.00 - Stable (19.92%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.000	2023-07-20
Last Dividend	INR1.000	2023-07-20
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR1.000	--
Avg. Dividend % Per Year	0.12%	--
Score	1.17	--
Div. Sustainability Score	3.45
Div.Growth Potential Score	4.00
Div. Directional Score	3.72	--

Next Divdend (Est)
(2024-05-06)

INR2.00 Estimate 2.50 %

Dividend Stability

0.20 Very Poor

Dividend Score

1.17

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2023	INR1.000	0.36%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SPIC.NS	Dividend Junior	2023-09-20	Annually	3	0.70%
MPHASIS.NS	Dividend Knight	2023-07-05	Annually	20	1.43%
HESTERBIO.NS	Dividend Junior	2023-09-13	Annually	10	0.31%
BIRLACABLE.NS	Dividend Junior	2023-09-04	Sporadic	11	0.93%
RAYMOND.NS	Dividend Junior	2023-06-23	Sporadic	29	0.15%
KOTARISUG.NS	Dividend Junior	2023-08-03	Sporadic	11	0.58%
EVERESTIND.NS	Dividend Junior	2023-08-14	Annually	22	0.75%
AMBIKCO.NS	Dividend Junior	2023-09-22	Annually	17	1.61%
SYRMA.NS	No Dividend Player	2023-09-01	Insufficient data to determine frequency	2	0.18%
NEWGEN.NS	Dividend Knight	2023-06-20	Annually	7	2.26%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0819	1.500	8.36	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0703	1.500	-0.330	-0.494	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	6.77	1.000	8.60	8.60	[3 - 30]
operatingCashFlowPerShareTTM	8.80	2.00	7.07	10.00	[0 - 30]
freeCashFlowPerShareTTM	8.80	2.00	5.60	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.553	1.000	4.12	4.12	[0.2 - 0.8]
operatingProfitMarginTTM	0.128	1.000	9.43	9.43	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.45

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	63.14	1.000	3.72	0	[1 - 100]
returnOnEquityTTM	0.0703	2.50	-0.212	-0.494	[0.1 - 1.5]
freeCashFlowPerShareTTM	8.80	2.00	7.07	10.00	[0 - 30]
dividendYielPercentageTTM	0.216	1.500	4.59	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.80	2.00	7.07	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	10.31	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0984	1.000	-0.0403	0	[0.1 - 0.5]
Total Score				4.00

Fortis Healthcare Limited

Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India, the United Arab Emirates, Sri Lanka, and internationally. Its healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. The company offers services in the areas of cardiac science, cosmetology, dental science, dermatology, diabetes/endocrinology, emergency medicine, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, haematology, infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, rheumatology, thoracic surgery, transplantation medicine, urology, and other support specialties. As of March 31, 2022, it operated a network of 26 hospitals with approximately 4,300 operational beds. The company also operates approximately 426 diagnostics centers and laboratories; and 2,550 collection centers. The company was incorporated in 1996 and is based in Gurugram, India.